San Francisco, CA (UroToday.com) The first of a planned 160 patients has been enrolled on a new cancer trial for the treatment of men with metastatic castration-resistant prostate cancer.
The ENZA-p trial, led by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), enrolled its first patient at Austin Health in Melbourne this week. The trial is being led by Associate Professor Louise Emmett from St Vincent’s Hospital Sydney.